Butaprost (free acid)

• CAT Number: R064541
• CAS Number: 433219-55-7
• Molecular Formula: C23H38O5
• Molecular Weight: 394.62
• Purity: ≥95%
• Synonyms: (±)-15-deoxy-16S-hydroxy-17-cyclobutyl PGE1;15-deoxy-16S-hydroxy-17-cyclobutyl PGE1
• Target: Prostaglandin Receptor
• Storage: -20°C
• InChI: InChI=1S/C23H38O5/c1-2-13-23(14-8-15-23)21(26)11-7-10-18-17(19(24)16-20(18)25)9-5-3-4-6-12-22(27)28/h7,10,17-18,20-21,25-26H,2-6,8-9,11-16H2,1H3,(H,27,28)/b10-7+/t17-,18-,20-,21+/m1/s1
• InChIKey: PAYNQYXOKJDXAV-ZHIWTBQHSA-N
• SMILES: CCCC1(CCC1)[C@@H](O)C/C=C/[C@H]([C@H]2CCCCCCC(O)=O)[C@H](O)CC2=O

Butaprost (CAT: R064541) is a synthetic analog of prostaglandin E2 (PGE2) that specifically acts as an agonist for the EP2 receptor, one of the four subtypes of prostaglandin E receptors. It is commonly used in research to study the physiological and pharmacological effects of EP2 receptor activation, such as vasodilation, bronchodilation, and modulation of inflammatory responses. Butaprost (free acid) is valuable in exploring the roles of EP2 receptors in conditions like asthma, cardiovascular diseases, and immune regulation. Its selectivity for the EP2 receptor makes it a key compound in the investigation of prostaglandin-related signaling pathways.